Literature DB >> 31370978

Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.

Michael D Stein1, Shannon R Kenney2, Bradley J Anderson3, Genie L Bailey4.   

Abstract

BACKGROUND: Fentanyl-adulterated heroin supply chains are increasing risks for fatal overdose in the U.S.
OBJECTIVE: The current study examined the use of overdose risk reduction behaviors among persons seeking treatment for heroin use and whether perceptions about the presence of fentanyl in one's heroin are associated with overdose risk reduction behaviors.
METHOD: We recruited persons with opioid use disorder entering a managed withdrawal program. We used multiple linear regression to estimate the adjusted associations of participant characteristics and perception of fentanyl exposure with the frequency of engaging in each of five overdose reduction behaviors.
RESULTS: Participants (n = 239; 75.3% male, 81.2% White, 67% injectors) estimated that 69.2% of the heroin they use contains fentanyl, and 94.6% knew that fentanyl increases overdose risk. Approximately 30% of respondents reported usually or always making sure others are around when they use heroin, carrying naloxone, taking "tester" doses of heroin or intentionally using in reduced amounts. While a majority of the sample reported never carrying naloxone or taking tester doses, and 70.2% reported never making sure that others around them carry naloxone, 84.5% had implemented one or more behavior at least rarely. Past month injection drug use was associated with making sure others are around, but perceptions about fentanyl in one's heroin were not associated with use of harm reduction behaviors.
CONCLUSIONS: In this sample of people who use heroin, although overdose risk reduction behaviors were not usually used, a majority had tried at least one behavior. That perceived exposure to fentanyl-adulterated heroin was not associated with the use of such behaviors provides important implications for public health education and intervention programming.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fentanyl; Harm reduction; Heroin; Overdose

Year:  2019        PMID: 31370978      PMCID: PMC6702957          DOI: 10.1016/j.jsat.2019.07.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  18 in total

1.  Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically.

Authors:  Alexandria Macmadu; Jennifer J Carroll; Scott E Hadland; Traci C Green; Brandon D L Marshall
Journal:  Addict Behav       Date:  2017-01-06       Impact factor: 3.913

2.  Expanding access to naloxone in the United States.

Authors:  Suzanne Doyon; Steven E Aks; Scott Schaeffer
Journal:  J Med Toxicol       Date:  2014-12

3.  Addressing the Fentanyl Threat to Public Health.

Authors:  Richard G Frank; Harold A Pollack
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

Review 4.  Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.

Authors:  Hilary Smith Connery
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

5.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

6.  Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2010-2014.

Authors:  Margaret Warner; James P Trinidad; Brigham A Bastian; Arialdi M Minino; Holly Hedegaard
Journal:  Natl Vital Stat Rep       Date:  2016-12

7.  Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Authors:  R Matthew Gladden; Pedro Martinez; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

Review 8.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

9.  'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting.

Authors:  Thomas Kerr; Will Small; Elaine Hyshka; Lisa Maher; Kate Shannon
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

Review 10.  Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria.

Authors:  Rebecca McDonald; John Strang
Journal:  Addiction       Date:  2016-03-30       Impact factor: 6.526

View more
  6 in total

1.  Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.

Authors:  Alexis V Rivera; Michelle L Nolan; Denise Paone; Sidney A Carrillo; Sarah L Braunstein
Journal:  Subst Abus       Date:  2022       Impact factor: 3.984

2.  "It's probably going to save my life;" attitudes towards treatment among people incarcerated in the era of fentanyl.

Authors:  Eliana Kaplowitz; Alexandria Macmadu; Traci C Green; Justin Berk; Josiah D Rich; Lauren Brinkley-Rubinstein
Journal:  Drug Alcohol Depend       Date:  2022-01-22       Impact factor: 4.852

3.  Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario.

Authors:  Davide Arillotta; Fabrizio Schifano; Flavia Napoletano; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Eugenio Aguglia; Alessandro Vento
Journal:  Front Neurosci       Date:  2020-03-18       Impact factor: 4.677

Review 4.  New and Emerging Opioid Overdose Risk Factors.

Authors:  Ralph Foglia; Anna Kline; Nina A Cooperman
Journal:  Curr Addict Rep       Date:  2021-04-22

5.  "It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.

Authors:  Sarah Bauerle Bass; Patrick J A Kelly; Sphoorti Pandit-Kerr; Jenine Pilla; Katherine Morris; Erin Larsen; Jennifer P Wisdom; Phillip R Torralva
Journal:  Front Public Health       Date:  2022-07-22

6.  Community overdose surveillance: Comparing substances collected from the death scene investigation to toxicology results.

Authors:  Tracy-Lynn E Lockwood; Philip Huynh; Alex Richard; Emily Sightes; Katie Bailey; Bradley Ray; Marya Lieberman
Journal:  Drug Alcohol Depend       Date:  2021-04-24       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.